Updates and Events
Update from LRA’s President on COVID-19 Vaccines in Lupus

January 14, 2020 Dear Friends, Happy New Year! On behalf of all of us at the Lupus Research Alliance (LRA), thank you so much for your kindness and generosity in 2020 and prior years. 2021 starts off with some exciting milestones for the lupus community including a new treatment for lupus nephritis. But  Recently, our […] READ MORE

Vaccines and Lupus: What to Know Amid COVID-19

January 14, 2021 LRA’s President and CEO Kenneth Farber taped this video series – Vaccines and Lupus: What to Know Amid COVID-19 – to explain what vaccines do, how the new COVID-19 vaccine technologies work, and what the LRA is doing to address questions on the safety of these new vaccines for people with lupus. […] READ MORE

Lupus Advocacy Delivers Again!

December 28, 2020 After much back and forth, last week the U.S. Congress passed the year-end spending deal, called the Omnibus, and President Trump signed it into law Sunday night.  It’s because of your efforts during the LRA’s Virtual Hill Day in March that the need to fund research for lupus and other medical conditions […] READ MORE

Existing Cancer Drug May Lower Inflammation in Autoimmune Diseases Like Lupus

December 14, 2020 In a recent study published in the Journal of Immunology, LRA-funded researcher Dr. John Zhang at Medical University of South Carolina found that a protein called Fli-1 causes immune cells to produce a molecule that causes inflammation. When Fli-1 was hindered by the chemotherapeutic drug camptothecin, immune cells produced fewer inflammatory molecules. […] READ MORE

New Survey Shows Education and Communication Gaps in Lupus Nephritis Care

1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus New York, NY– December 7.  Significant gaps in education and communication among patients and physicians pose barriers to lupus nephritis (LN) care, according to results of two companion surveys conducted by the National Kidney Foundation (NKF) and the Lupus Research Alliance (LRA). Half of […] READ MORE

LRA-Supported Study Finds Similarities in the Immune Response Between Severe COVID-19 and Lupus Antiphospholipid Syndrome

December 2, 2020 The immune response during severe COVID-19 is similar to a lupus complication known as antiphospholipid syndrome, according to a study partly funded by the Lupus Research Alliance. Dr. Jason Knight and his colleagues including rheumatologist Yu (Ray) Zuo and cardiologist Yogen Kanthi reported that 52% of patients hospitalized with severe COVID-19 had […] READ MORE

Give the Lupus Community a Priceless Gift on Giving Tuesday

November 30, 2020 Every year, on December 1, the world shows its heartfelt support for the Lupus Research Alliance and other non-profit organizations. Giving Tuesday “is a global generosity movement unleashing the power of people and organizations to transform their communities and the world.” Donate here to give the most priceless gift – research to […] READ MORE

Learn and connect with our community!